MedTrace Logo

Increasing Physical Activity Among Breast Cancer Survivors With Depression

NCT02781051 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2019-02-22

Study results available
· View outcomes & findings →

Summary

Pilot study to assess a multi-component intervention to increase physical activity among breast cancer survivors with depression.

Conditions

Interventions

BEHAVIORAL

Print-based education

All subjects will be given a copy of Exercise for Health: An Exercise Guide for Breast Cancer Survivors. Topics covered within the book include benefits of exercise in breast cancer survivors; recommendations on type, duration, frequency and intensity of exercise; goal-setting; and advice on overcoming barriers.

DEVICE

Fitbit

Subjects will be provided with a commercially available activity monitor (i.e., Fitbit) and instructed to wear the device daily.

BEHAVIORAL

Active Living counseling

The Active Living counseling program consists of 12 weekly group educational sessions, facilitated by project interventionists. These sessions will involve discussion of topics related to increasing physical activity, including: identifying and overcoming barriers, setting goals, and time management.

OTHER

Facility Access

Subjects will have access to the exercise lab in the UT Southwestern Depression Center consisting of equipment for aerobic exercise (treadmills, stationary bikes, etc.).

Sponsors & Collaborators

  • American Cancer Society, Inc.

    collaborator OTHER

  • University of Texas Southwestern Medical Center

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02781051 on ClinicalTrials.gov